Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
6,219,909
-
Shares change
-
+888,162
-
Total reported value, excl. options
-
$6,073,000
-
Value change
-
+$587,717
-
Put/Call ratio
-
114%
-
Number of buys
-
9
-
Number of sells
-
-14
-
Price
-
$0.9763
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2021
39 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,219,909 shares
.
Largest 10 shareholders include Mirae Asset Global Investments Co., Ltd. (1,661,393 shares), Davy Global Fund Management Ltd (1,579,278 shares), BlackRock Inc. (861,214 shares), VANGUARD GROUP INC (654,728 shares), GEODE CAPITAL MANAGEMENT, LLC (292,489 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (288,155 shares), STATE STREET CORP (169,778 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (139,000 shares), DEARBORN PARTNERS LLC (96,901 shares), and BANK OF AMERICA CORP /DE/ (90,320 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.